These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 15919773

  • 1. IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression.
    Bjercke S, Fedorcsak P, Abyholm T, Storeng R, Ertzeid G, Oldereid N, Omland A, Tanbo T.
    Hum Reprod; 2005 Sep; 20(9):2441-7. PubMed ID: 15919773
    [Abstract] [Full Text] [Related]

  • 2. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
    Cabrera RA, Stadtmauer L, Mayer JF, Gibbons WE, Oehninger S.
    Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
    [Abstract] [Full Text] [Related]

  • 3. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY, Guu HF, Yi YC, Chen MJ, Ho ES.
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates.
    Lahoud R, Al-Jefout M, Tyler J, Ryan J, Driscoll G.
    Hum Reprod; 2006 Oct; 21(10):2645-9. PubMed ID: 16785261
    [Abstract] [Full Text] [Related]

  • 7. LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH.
    Peñarrubia J, Fábregues F, Creus M, Manau D, Casamitjana R, Guimerá M, Carmona F, Vanrell JA, Balasch J.
    Hum Reprod; 2003 Dec; 18(12):2689-97. PubMed ID: 14645193
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles.
    Tesarik J, Hazout A, Mendoza-Tesarik R, Mendoza N, Mendoza C.
    Hum Reprod; 2006 Oct; 21(10):2572-9. PubMed ID: 16926261
    [Abstract] [Full Text] [Related]

  • 11. Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?
    Orvieto R, Meltzer S, Rabinson J, Gemer O, Anteby EY, Nahum R.
    Fertil Steril; 2008 Oct; 90(4):1297-300. PubMed ID: 18249369
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, Van Steirteghem A, Devroey P.
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.